Dr. Mink Chawla

And then terrible things happen to us. So if we can not just move from this inpatient space where this filter has started, we're now moving into the outpatient space. We're starting a long COVID clinical trial right now.

And we're seeing extraordinary results from people. We have people with chronic EBV, chronic Lyme, and we have these cases where it's like, wow, this is, so if you can take a person, so in the future, we aspire to take people with this like tick-borne illnesses that can't clear it through modern medicine. We can now bring something to bear to help the immune system reboot, get back on it.

And we're seeing extraordinary results from people. We have people with chronic EBV, chronic Lyme, and we have these cases where it's like, wow, this is, so if you can take a person, so in the future, we aspire to take people with this like tick-borne illnesses that can't clear it through modern medicine. We can now bring something to bear to help the immune system reboot, get back on it.

And we're seeing extraordinary results from people. We have people with chronic EBV, chronic Lyme, and we have these cases where it's like, wow, this is, so if you can take a person, so in the future, we aspire to take people with this like tick-borne illnesses that can't clear it through modern medicine. We can now bring something to bear to help the immune system reboot, get back on it.

For sure. But the most important thing is just like HIV... We have not cured HIV, AIDS. I practiced at a time where many, many people died in front of me with AIDS. Then I watched highly active retroviral therapy come to bear. Magic Johnson is alive and well and he's a billionaire and he's killing it. And he still has HIV. So to your point precisely-

For sure. But the most important thing is just like HIV... We have not cured HIV, AIDS. I practiced at a time where many, many people died in front of me with AIDS. Then I watched highly active retroviral therapy come to bear. Magic Johnson is alive and well and he's a billionaire and he's killing it. And he still has HIV. So to your point precisely-

For sure. But the most important thing is just like HIV... We have not cured HIV, AIDS. I practiced at a time where many, many people died in front of me with AIDS. Then I watched highly active retroviral therapy come to bear. Magic Johnson is alive and well and he's a billionaire and he's killing it. And he still has HIV. So to your point precisely-

If the immune system can put that virus back in jail, I don't care. Right. He just can't be meandering the streets, you know, shooting people.

If the immune system can put that virus back in jail, I don't care. Right. He just can't be meandering the streets, you know, shooting people.

If the immune system can put that virus back in jail, I don't care. Right. He just can't be meandering the streets, you know, shooting people.

Retroviral, yeah. Our genome has retrovirus in it. And when you get very, very sick, those genes start coming out. Now, there's probably some evolutionary reasons why we incorporated them in, because it has a higher mutation rate, so that helps us evolve a little bit faster.

Retroviral, yeah. Our genome has retrovirus in it. And when you get very, very sick, those genes start coming out. Now, there's probably some evolutionary reasons why we incorporated them in, because it has a higher mutation rate, so that helps us evolve a little bit faster.

Retroviral, yeah. Our genome has retrovirus in it. And when you get very, very sick, those genes start coming out. Now, there's probably some evolutionary reasons why we incorporated them in, because it has a higher mutation rate, so that helps us evolve a little bit faster.

From grandfather to son to grand, like on and on it goes. Yes. And it has given us an advantage. But like every advantage, it can become a weakness. It can become a vulnerability. And so I very much agree with this notion of being able to surveil patients if they have chronic viremias, if they have chronic tick-borne illnesses. This, I think, is going to be a really powerful tool.

From grandfather to son to grand, like on and on it goes. Yes. And it has given us an advantage. But like every advantage, it can become a weakness. It can become a vulnerability. And so I very much agree with this notion of being able to surveil patients if they have chronic viremias, if they have chronic tick-borne illnesses. This, I think, is going to be a really powerful tool.

From grandfather to son to grand, like on and on it goes. Yes. And it has given us an advantage. But like every advantage, it can become a weakness. It can become a vulnerability. And so I very much agree with this notion of being able to surveil patients if they have chronic viremias, if they have chronic tick-borne illnesses. This, I think, is going to be a really powerful tool.

It is astonishing what those numbers look like. So I think it depends on why folks are getting treated. So people with acute infection or chronic infection, if you happen to have PCR positive viral particles in your blood, they had a very easy thing to do is say, hey, did we take that titer down? Do we make it undetectable? And we've done that.

It is astonishing what those numbers look like. So I think it depends on why folks are getting treated. So people with acute infection or chronic infection, if you happen to have PCR positive viral particles in your blood, they had a very easy thing to do is say, hey, did we take that titer down? Do we make it undetectable? And we've done that.

It is astonishing what those numbers look like. So I think it depends on why folks are getting treated. So people with acute infection or chronic infection, if you happen to have PCR positive viral particles in your blood, they had a very easy thing to do is say, hey, did we take that titer down? Do we make it undetectable? And we've done that.

We've had cases where people were EBV positive and then they were done, they were EBV undetectable. So that's like an amazing, cool thing. For people with chronic Lyme, we've had some really extraordinary case reports on this. And for them, you can't measure Lyme so easily in the blood, but there's these other Lyme surrogates. So I think it's a little personalized.